Hopwood Financial Services Inc. purchased a new stake in Colgate-Palmolive (NYSE:CL – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 3,270 shares of the company’s stock, valued at approximately $297,000.
A number of other hedge funds and other institutional investors also recently modified their holdings of CL. Swedbank AB boosted its position in Colgate-Palmolive by 1.4% during the third quarter. Swedbank AB now owns 2,950,059 shares of the company’s stock worth $306,246,000 after purchasing an additional 40,324 shares during the period. Baker Avenue Asset Management LP raised its holdings in Colgate-Palmolive by 10.9% in the 3rd quarter. Baker Avenue Asset Management LP now owns 4,958 shares of the company’s stock valued at $515,000 after acquiring an additional 487 shares during the period. Ashton Thomas Securities LLC acquired a new stake in Colgate-Palmolive during the third quarter worth approximately $109,000. Kennebec Savings Bank bought a new stake in shares of Colgate-Palmolive during the third quarter worth approximately $91,000. Finally, Catalytic Wealth RIA LLC acquired a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $362,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Trading Down 3.5 %
CL stock opened at $94.05 on Wednesday. The company has a market capitalization of $76.32 billion, a price-to-earnings ratio of 26.72, a PEG ratio of 4.20 and a beta of 0.40. The business has a 50 day simple moving average of $89.03 and a two-hundred day simple moving average of $94.99. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on CL. JPMorgan Chase & Co. dropped their price target on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Finally, Barclays reduced their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $101.61.
Get Our Latest Research Report on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- Financial Services Stocks Investing
- Beyond a Market Correction, Moves to Make Now
- Growth Stocks: What They Are, Examples and How to Invest
- 3 Dividend Picks Standing Strong as Bond Yields Fall
- 3 REITs to Buy and Hold for the Long Term
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.